CHUK and COVID-19: Notably, we discovered that CHUK, PSTPIP1, and CCL3, upregulated in both COVID-19 and CAD, were associated with the upregulation of many inflammatory pathways in both conditions, including the IL12, IL10, IL23, and P53 regulation pathways (See Appendix A, Figure A2C).